Clinical Trial Update: Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing the Titan stent with a zotarolimus-eluting stent in coronary heart disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Titan Stent
• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: University of Bern | Conditions: Coronary Heart Disease | Phase 4 | Status: COMPLETED